Karen Wills

My interests lie broadly in understanding the molecular basis of disease processes, which were founded during my Medical Biochemistry (2003) and Immunology (2000) B.Sc. (Hons) studies at the University of Glasgow. I first became interested in using mass spectrometry and proteomic approaches to investigate biological processes during my Ph.D. research in the laboratory of Dr. Peter Flatman at the Centre for Integrative Physiology, University of Edinburgh (2008). I have had the opportunity to significantly increase these skills as a postdoc within the Rappsilber laboratory, where I now work in the pioneering fields of chromatin proteomics and 3D proteomics.

Research Overview
I have two main areas of research in the Rappsilber laboratory.
(i) Chromatin Proteomics of Breast Cancer
This work involves probing the chromatin proteome as a cellular source of biomarkers of breast cancer. I aim to identify the molecular features associated with hormone and drug resistance in breast cancer, in particular the changes that occur on chromatin when tumours become resistant to treatment with endocrine therapy. The ultimate aim of this work is to identify proteins that can be used as biomarkers and alternative therapeutic targets.
(ii) 3D Proteomics of Chromatin
The aim of this research is to determine the interactions between proteins on chromatin and understand their molecular architecture, particularly in the mitotic chromosome. This involves a melding of the lab’s major foci of 3D and chromatin proteomics, and some collaborative activities with the Earnshaw lab within the Wellcome Trust Centre for Cell Biology.